Singapore opens research centre for circulating tumour cell
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: National Cancer Centre Singapore (NCCS) and Clearbridge BioMedics, in partnership with the Pathology Departme...Read more
TauRx gets $10.5 mn funding from Dundee Corp
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 05 Mar, 2013
Singapore: Singapore-based TauRx Pharmaceuticals recieved equity investment of $10.5 million from Toronto's Dundee Corpo...Read more
FDA: AbbVie Hepatitis therapy is a 'breakthrough'
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 May, 2013
Singapore: AbbVie's investigational direct-acting antiviral (DAA) combination with and without ribavirin for the treatme...Read more
NIH to develop therapeutics for nicotine addiction
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 01 Aug, 2013
Singapore: The National Institutes of Health (NIH), US, has launched three projects that will focus on development of t...Read more
NZ firm to raise funds for Australia trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 Sep, 2012
Singapore: Innate Immunotherapeutics, a New Zealand-based company, will raise further funds in the second half of 2012 t...Read more
TSRI, Takeda expand research collaboration
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Mar, 2013
Singapore: The Scripps Research Institute (TSRI) and Takeda Pharmaceutical plan to expand their recent research collabo...Read more
Prima recruits patients for cancer vaccine trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 01 Mar, 2013
Singapore: Prima BioMed has commenced recruitment of patients into the Canvas (Cancer Vaccine Study) trial in Europe. P...Read more
Merck pays Bionomics $172mn for pain molecules
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 01 Aug, 2013
Singapore: Bionomics entered in an agreement with Merck, which is also known as Merck Sharp and Dohme outside the US and...Read more
Bayer initiates trial of new rFVIII to treat hemophilia A
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2012
Singapore: Bayer HealthCare started enrolling patients in an international phase II/III trial called PROTECT VIII that i...Read more
Eli Lilly, China firm to co-develop diabetes drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 Jul, 2014
‎Singapore: China based pharmaceutical company, Yabao Pharmaceutical, has partnered with Eli Lilly to co-develop L...Read more
ScinoPharm, Coland develop cancer generics in China
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 13 May, 2013
‎Singapore: ScinoPharm Taiwan and Taiwan-listed, China-based company, Coland, have formed a strategic alliance to ...Read more
VM202 trial completes patient administration
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 13 Jun, 2013
Singapore: ViroMed, a leading biotechnology company, announced the final enrollment and administration of 105 patients f...Read more
Researchers find gene mutation to lower heart disease
Drug Discovery | News | By BioSpectrum Bureau | 1 Comment | 24 Apr, 2013
Singapore: By scouring the DNA of thousands of patients, researchers at Broad Institute, Massachusetts General Hospital,...Read more
EMA to review marketing plea for antipsychotic medication
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2012
Singapore: The European Medicines Agency (EMA) has accepted the marketing authorization application for review of an aty...Read more
Chipscreen gets SFDA nod after accelerated review
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 17 Apr, 2013
‎Singapore: China-based Chipscreen Biosciences announced the achievement of the primary endpoint in the pivotal, r...Read more
FDA affirms superiority of Pradaxa over warfarin
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 Jun, 2012
Singapore: US Food and Drug Administration has affirmed Boehringer Ingelheim's Pradaxa 150mg superior in reducing ischem...Read more
Sanofi withdraws diabetes drug NDA in the US
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 13 Sep, 2013
Singapore: Global pharmaceutical company, Sanofi has temporarily withdrawn new drug application (NDA) for lixisenatide i...Read more
Amgen to acquire Onyx for $10 bn cash
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 26 Aug, 2013
Singapore: Global biopharmaceutical company Amgen plans to acquire all the outstanding shares of Onyx Pharmaceuticals fo...Read more